2015-10-05

UVLrx Therapeutics Introduces UV LED Therapy Device to EU Consumers

UVLrx Therapeutics announces that it has received CE marking to commercially sell its UVLrx 1500 multi-wavelength, intravenous light therapy system in the European Union. The UVLrx 1500 System offers the first intravenous, concurrent delivery of ultraviolet-A (UVA) and multiple visible light wavelengths. Using the company’s patent pending Dry Light Adapter™ and a standard I.V. catheter, the UVLrx 1500 eliminates the need for removal of blood from the body.
Continue reading

Seoul Viosys, a global opto-semiconductor device company, announced that it is participating in K-Display 2026, held at COEX in Seoul from July 22 to 24, where it is showcasing next-generation opto-semiconductor technologies and has received t... READ MORE

What Is RGB Backlight? A Next-Generation Display Technology That Enhances Color Gamut and Optical Efficiency with RGB LEDs Competition in the display industry is expanding beyond brightness and resolution to include color accuracy and energy e... READ MORE